Want to join the conversation?
$DNB 2Q15 Q&A: Appert from Piper Jaffray asked about competitive issues as an impediment to faster revenue growth in credit business. Bod replied with respect to the traditional credit risk market, we're not really seeing a material change in the competitive landscape. You can see in our results that we somewhat stabilized the DNBi performance.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.